Listar por autor "Delaugerre, Constance"
Mostrando ítems 1-6 de 6
-
Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
Castro, Nathalie de et al. | Fecha del documento: 2022 -
Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy
Delagreverie, Héloïse M. et al. | Fecha del documento: 2020 -
Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial
Coelho, Lara E. et al. | Fecha del documento: 2024 -
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
Grinsztejn, Beatriz et al. | Fecha del documento: 2014 -
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial
Castro, Nathalie de et al. | Fecha del documento: 2021 -
Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high tuberculosis burden countries
Castro, Nathalie De et al. | Fecha del documento: 2023